Recombinant Human COX17 Protein, N-GST & C-His

Description of Recombinant Human COX17 Protein, N-GST & C-His

Introduction

Recombinant Human COX17 Protein is a highly purified and biologically active protein that plays a crucial role in the assembly and function of cytochrome c oxidase (COX), the terminal enzyme of the mitochondrial electron transport chain. This protein is produced through recombinant DNA technology, which involves the insertion of the COX17 gene into a host cell and subsequent expression and purification of the protein. In this article, we will discuss the structure, activity, and applications of Recombinant Human COX17 Protein.

Structure of Recombinant Human COX17 Protein

The COX17 gene encodes for a protein of 91 amino acids, which is then processed into a mature protein of 79 amino acids. The recombinant protein is produced in a prokaryotic or eukaryotic expression system and is purified to a high level of homogeneity. Recombinant Human COX17 Protein has a molecular weight of approximately 9 kDa and is composed of a single polypeptide chain with a conserved CxxC motif, which is essential for its function.

The crystal structure of Recombinant Human COX17 Protein has been determined, revealing a compact folded structure with a β-sheet core and three α-helices. The CxxC motif is located at the N-terminus and forms a disulfide bond, which is critical for the protein’s activity. The structure also contains a hydrophobic pocket that is involved in the binding of copper ions, which are essential for COX17’s function as a copper chaperone.

Activity of Recombinant Human COX17 Protein

Recombinant Human COX17 Protein is a copper chaperone that plays a crucial role in the maturation of COX. COX17 binds to copper ions and delivers them to the mitochondrial inner membrane, where they are incorporated into COX. This process is essential for the proper assembly and function of COX, which is responsible for the final step in the mitochondrial electron transport chain, the reduction of oxygen to water.

Studies have shown that mutations in the COX17 gene can lead to deficiencies in COX activity, resulting in mitochondrial dysfunction and various diseases, including Leigh syndrome and cardiomyopathy. Recombinant Human COX17 Protein has been used in research to study the role of COX17 in these diseases and to develop potential therapeutic interventions.

Applications of Recombinant Human COX17 Protein

Recombinant Human COX17 Protein has a wide range of applications in both research and industrial settings. In research, it is used as a tool to study the structure and function of COX17 and its role in COX assembly and function. It is also used to investigate the mechanisms of mitochondrial diseases and to develop potential treatments.

In the industrial sector, Recombinant Human COX17 Protein is used in the production of COX-based biosensors, which are used for the detection of toxic compounds that interfere with COX activity. These biosensors have applications in environmental monitoring and drug discovery.

Furthermore, Recombinant Human COX17 Protein has potential therapeutic applications. It has been shown to rescue COX activity in cells with COX17 mutations and has been proposed as a potential treatment for COX deficiencies. Additionally, it has been investigated as a potential therapeutic target for cancer, as COX17 has been found to play a role in the survival and proliferation of cancer cells.

Conclusion

Recombinant Human COX17 Protein is a biologically active protein that plays a crucial role in the assembly and function of COX, the terminal enzyme of the mitochondrial electron transport chain. Its structure, activity, and applications make it a valuable tool in research and industry, with potential therapeutic applications in the future. Further studies on this protein will continue to enhance our understanding of its role in health and disease.